Investigators have detected that the higher frequencies of IFNγ-producing CD4+ T cells and higher amount of secreted IFNγ before the induction treatment are characteristic of patients who do not show tumour recurrence at 6 months. The gene discussed is IFNG; the disease is neoplasm.